Variable Univariate analysis Multivariable analysis
OR [95 CI] p-value OR [95 CI] p-value
Age
≥ 70 vs < 70 yrs 1.01 [0.99-1.02] 0.58
Sexe
Female vs Male 1.02 [0.62-1.68] 0.94
Initial daily dose
< 800 vs 800 mg 1.38 [0.83-2.30] 0.22 1.01 [0.58-1.77] 0.97
PAZ Cmin at D15
< 27 vs ≥ 27 mg/L 1.57 [0.95-2.61] 0.08 1.62 [0.97-2.72] 0.07
Histological subtype
Leiomyosarcoma vs other 1.08 [0.62-1.87] 0.8 1.19 [0.67-2.13] 0.55
Synovial sarcoma vs other 0.71 [0.30-1.70] 0.45 0.86 [0.35-2.09] 0.74
Tumour grade*
Grade 3 vs 1-2 1.72 [0.94-3.18] 0.08
Metastatic sites
Bone metastasis 1.78 [1.07-2.97] 0.03 1.42 [0.82-2.47] 0.22
Lymph node metastasis 0.98 [0.57-1.67] 0.93
ECOG PS
≥ 2 vs 0-1 2.54 [1.49-4.33] 0.0006 2.31 [1.26-4.23] 0.007
Previous treatments
≥ 2 vs 0-1 previous lines 1.44 [0.86-2.41] 0.17
BMI
> 25 vs ≤ 25 kg/m2 1.41 [0.85-2.33] 0.19
Albumin
≥ 35 vs < 35 g/L 1.07 [0.53-2.18] 0.85
NLR
≥ 3.5 vs < 3.5 1.00 [0.60-1.67] 0.99